Aripiprazole Completed Phase 4 Trials for Schizoaffective Disorders / Schizophrenia Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00330863Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
NCT00304655Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)
NCT00325689Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.
NCT00423878Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
NCT00520650Health Evaluation of Abilify Long-term Therapy
NCT02237417Study of the Impact of Aripiprazole (Abilify®) Once Monthly Versus Standard of Care Oral Antipsychotic Medications on Changes in Brain Structure and Metabolism
NCT02697045Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch
NCT00634348A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients
NCT00044655Switching Medication to Treat Schizophrenia
NCT00088049Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia
NCT00080327Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia
NCT00103571Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia
NCT00167817Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study
NCT00232687A Switch Study of BMS-337039 in Schizophrenic Out-patients
NCT00300846A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients
NCT00304616SWitching to Abilify Trial (SWAT)
NCT00320671Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis
NCT00329810Effect on Cognitive Function of a Treatment With Aripiprazole
NCT00328367Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia
NCT00351936A Placebo-Controlled, Cross-Over Trial of Aripiprazole
NCT00392197Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-
NCT00802100Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
NCT01052389Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia
NCT01164059Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia
NCT01714011Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome